About Acino
Acino is specialized on the development, registration and manufacture of generic and innovative pharmaceuticals using advanced drug delivery technologies for which Acino also holds patents.
With a focus on solid oral dosage forms with modified release of the active ingredient, transdermal therapeutic patches and biodegradable, subcutaneous implants, Acino supplies leading pharmaceutical companies throughout Europe. Acino offers the pharmaceuticals industry a comprehensive range of services from product development and registration to sourcing, contract manufacturing, packaging and logistics.
The Acino Group is headquartered in Basle, currently employs approximately 380 staff and generated annual net revenues of about CHF 230 million in 2008. Acino Holding Ltd., the Group’s parent, is listed on the SIX Swiss Exchange (SIX: ACIN).
- Focus : Manufacturer
- Industry : Pharma
